Soumyasri Kambhatla, MD
Rheumatology · Jonesboro, ARNPI 1851820005
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $605 of the $705 with a category attached, or 85.8%. It is spread thinly across 10 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $329 and has fallen 62.9% since, to $122 in 2025. That places this record below the midpoint for rheumatology clinicians in AR, where the typical reported total is $4,419.
Across 28 payments — averaging $25.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$149
- Johnson & Johnson$135
- Amgen$113
- Pfizer$95
- Lilly USA, LLC$93
- Aurinia Pharma U.S., Inc.$53
- plus $67 from 4 others
What the payments were for
- Food & beverage$60586%
- Education$10014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 3 | $149 |
| Johnson & Johnson | 3 | $135 |
| Amgen | 7 | $113 |
| Pfizer | 4 | $95 |
| Lilly USA, LLC | 5 | $93 |
| Aurinia Pharma U.S., Inc. | 2 | $53 |
| GSK | 1 | $20 |
| Sandoz | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $14 |
| Novo Nordisk | 1 | $14 |
How this compares
$705 in reported general payments places this provider in the 25th percentile of 48 rheumatology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 115 | $4,632 |
| Gabapentin | 120 | $3,320 |
| Duloxetine Hcl | 125 | $2,798 |
| MethotrexateMethotrexate Sodium | 202 | $2,388 |
| Pregabalin | 40 | $2,292 |
| Leflunomide | 24 | $2,199 |
| Colchicine | 22 | $1,556 |
| Mycophenolate Mofetil | 11 | $813 |
| Tramadol Hcl | 87 | $675 |
| Amitriptyline Hcl | 52 | $542 |
| Prednisone | 76 | $517 |
| Alendronate Sodium | 62 | $445 |
| Cyclobenzaprine Hcl | 50 | $361 |
| Sulfasalazine DrSulfasalazine | 17 | $346 |
| Diclofenac Sodium | 25 | $302 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Jonesboro
- Beata Filip-MajewskiJonesboro$14K
- Leslie McCaslandJonesboro$9K
- Randy RobertsJonesboro$124
- Russell BranumFort Smith$102K
- Cummins LueLittle Rock$76K
- Shailendra SinghSearcy$67K
- Christopher SonntagFayetteville$32K
- Jasen ChiLittle Rock$30K
- Richard HoukLittle Rock$25K
- Noha MohamedConway$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.